”), the subsidiary, has indicated the growth by 12.35%. Costs and Expenses  The Company reported the consolidated costs and expenses for Q3/2019 of Baht 365.61 million representing a slightly increase by

million, a 9 .74% or Baht 37.72 million growing up from the same period of previous year. The hospital revenues grew by 10.04% mainly due to the increase in medical service income from Social Security

SMEs for funding in order to develop their potential and increase their ability to compete both domestically and internationally which is SEC's mission under the master plan of the 20-Year National

480 (188) (39.1) Others 22 3 19 614.0 Interest expenses totaled Baht 5,033 million, an increase of 19.4% yoy from the growth in deposit consistent with the overall expansion in loan portfolio. Cost of

1.11% from the same period of the prior year. The total revenue was 1,036.22 million baht, an increase of 25.83 million baht or 2.56% . Interest expenses were 263. 73 million baht, an increase of 38. 34

the consolidate financial statement has net loss 3.40 Million Baht, increase of 21.29 Million Baht or 119.01% comparing to the last year. Loss attributable to equity holders of the parent is 5.61

, compared with the same period of the previous year. Baht 1.57 million or an increase of Baht 32.73 million or an increase of 2,084.71% from the following reasons. 1. Sales and services income decreased

its subsidiaries recorded net profit of 10,463 million baht, increase of 12 million baht or increase by 0.11% 1. In the year 2018, the Company recorded sales income in an amount of 30,514 million baht

increase of 17% and recorded net profit of THB 848 million compare to net profit of THB 1,970 million at the same period last year, representing a decrease of 57%. The details were as followings; Total

 127.58 million or 16.42%  increase year‐over‐year  from THB 109.59 million  in  1Q19.   This represents an  increase  in  the cost of doctors, nurses, drugs, medical supplies and new  building